No evidence of hSNF5/INI1 point mutations in choroid plexus papilloma
暂无分享,去创建一个
C. Sarkar | A. von Deimling | W. Bruck | W. Paulus | W. Mueller | U. Lass | J. Eum | Joo-Hun David Eum
[1] J. Biegel,et al. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[2] O. Delattre,et al. A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle , 2002, Oncogene.
[3] J. Minna,et al. MYO18B, a candidate tumor suppressor gene at chromosome 22q12.1, deleted, mutated, and methylated in human lung cancer , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[4] G R Taylor,et al. Investigations on a clinically and functionally unusual and novel germline p53 mutation , 2002, British Journal of Cancer.
[5] I. Frayling,et al. Methods of molecular analysis: mutation detection in solid tumours , 2002, Molecular pathology : MP.
[6] O. Wiestler,et al. Chromosomal imbalances in choroid plexus tumors. , 2002, The American journal of pathology.
[7] A. von Deimling,et al. Mutational analysis of INI1 in sporadic human brain tumors , 2001, Acta Neuropathologica.
[8] M. Brada. Pathology and Genetics of Tumours of the Nervous System , 2001, British Journal of Cancer.
[9] A. Deimling,et al. INI1 mutations in meningiomas at a potential hotspot in exon 9 , 2001, British Journal of Cancer.
[10] C. James,et al. Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous system. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[11] J. Drake,et al. Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene. , 2000, American journal of human genetics.
[12] O. Delattre,et al. Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. , 1999, American journal of human genetics.
[13] O. Delattre,et al. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors. , 1999, Cancer research.
[14] G. Crabtree,et al. Continuous and widespread roles for the Swi–Snf complex in transcription , 1999, The EMBO journal.
[15] R. Kingston,et al. Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. , 1999, Molecular cell.
[16] A. Nataraj,et al. Single‐strand conformation polymorphism and heteroduplex analysis for gel‐based mutation detection , 1999, Electrophoresis.
[17] P. Kleihues,et al. Astrocytomas and Choroid Plexus Tumors in Two Families with Identical p53 Germline Mutations , 1998, Journal of neuropathology and experimental neurology.
[18] B. Emerson,et al. A SWI/SNF–Related Chromatin Remodeling Complex, E-RC1, Is Required for Tissue-Specific Transcriptional Regulation by EKLF In Vitro , 1998, Cell.
[19] Olivier Delattre,et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer , 1998, Nature.
[20] R. Mccomb,et al. Pathology and Genetics of Tumours of the Nervous System , 1998 .
[21] M. Barat,et al. WELL DEMARCATED AREAS OF DEMYELINATION-REMYELINATION IN AN ASYMMETRIC POLYNEUROPATHY WITH A STEPWISE PROGRESSIVE COURSE , 1998 .
[22] V. Jay,et al. P53 expression in choroid plexus neoplasms: an immunohistochemical study. , 1996, Archives of pathology & laboratory medicine.
[23] M. Yaniv,et al. Purification and biochemical heterogeneity of the mammalian SWI‐SNF complex. , 1996, The EMBO journal.
[24] D. Louis,et al. A rapid and non‐radioactive PCR based assay for the detection of allelic loss in human gliomas , 1993, Neuropathology and applied neurobiology.